AR052474A1 - METHOD OF QUANTITATIVE MEASUREMENT BY IMMUNOCROMATOGRAPHY OF ANALYTS IN A LIQUID SAMPLE - Google Patents

METHOD OF QUANTITATIVE MEASUREMENT BY IMMUNOCROMATOGRAPHY OF ANALYTS IN A LIQUID SAMPLE

Info

Publication number
AR052474A1
AR052474A1 ARP060100400A ARP060100400A AR052474A1 AR 052474 A1 AR052474 A1 AR 052474A1 AR P060100400 A ARP060100400 A AR P060100400A AR P060100400 A ARP060100400 A AR P060100400A AR 052474 A1 AR052474 A1 AR 052474A1
Authority
AR
Argentina
Prior art keywords
liquid sample
quantitative measurement
immunocromatography
analyts
analyte
Prior art date
Application number
ARP060100400A
Other languages
Spanish (es)
Original Assignee
Stago Diagnostica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0501145A external-priority patent/FR2881828B1/en
Application filed by Stago Diagnostica filed Critical Stago Diagnostica
Publication of AR052474A1 publication Critical patent/AR052474A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Abstract

La presente tiene como objeto un método de medicion cuantitativa de por lo menos un analito de interés en una muestra líquida, por inmunocromatografía, donde dicho método comprende una medicion ponderada de la cantidad de analito, en relacion a un control. El método se aplica, en particular, al diagnostico médico en el campo de la hemostasis, por ejemplo para excluir un riesgo de diagnostico de enfermedad tromboembolítica venosa.The present object is a quantitative measurement method of at least one analyte of interest in a liquid sample, by immunochromatography, wherein said method comprises a weighted measurement of the amount of analyte, in relation to a control. The method applies, in particular, to the medical diagnosis in the field of hemostasis, for example to exclude a risk of diagnosis of venous thromboembolic disease.

ARP060100400A 2005-02-04 2006-02-03 METHOD OF QUANTITATIVE MEASUREMENT BY IMMUNOCROMATOGRAPHY OF ANALYTS IN A LIQUID SAMPLE AR052474A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0501145A FR2881828B1 (en) 2005-02-04 2005-02-04 METHOD OF QUANTITATIVE MEASUREMENT BY IMMUNOCHROMATOGRAPHY, ANALYTES IN A LIQUID SAMPLE
FR0509097A FR2881829B1 (en) 2005-02-04 2005-09-06 METHOD AND DEVICE FOR QUANTITATIVE DOSING BY IMMUNOCHROMATOGRAPHY.

Publications (1)

Publication Number Publication Date
AR052474A1 true AR052474A1 (en) 2007-03-21

Family

ID=36337637

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060100400A AR052474A1 (en) 2005-02-04 2006-02-03 METHOD OF QUANTITATIVE MEASUREMENT BY IMMUNOCROMATOGRAPHY OF ANALYTS IN A LIQUID SAMPLE

Country Status (3)

Country Link
EP (1) EP1844332A1 (en)
AR (1) AR052474A1 (en)
WO (1) WO2006082318A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2462444B1 (en) 2009-08-07 2018-10-03 Affinimark Technologies, Inc. Methods for the immunological identification of cerebrospinal fluid
WO2019060270A1 (en) * 2017-09-21 2019-03-28 Becton, Dickinson And Company High dynamic range assays in hazardous contaminant testing

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935346A (en) * 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US5569608A (en) * 1995-01-30 1996-10-29 Bayer Corporation Quantitative detection of analytes on immunochromatographic strips
US5719034A (en) * 1995-03-27 1998-02-17 Lifescan, Inc. Chemical timer for a visual test strip
FR2788856B1 (en) * 1999-01-21 2001-07-13 Adiatec Sa TEST DEVICE AND METHOD FOR QUANTIFYING RESULTS OBTAINED BY IMMUNOCHROMATOGRAPHIC METHODS
US6509196B1 (en) * 2000-01-04 2003-01-21 Response Biomedical Corp. Compensation for non-specific signals in quantitative immunoassays
US20030162236A1 (en) * 2001-03-26 2003-08-28 Response Biomedical Corporation Compensation for variability in specific binding in quantitative assays
US6673617B2 (en) * 2002-03-14 2004-01-06 Lifescan, Inc. Test strip qualification system
GB0312403D0 (en) * 2003-05-29 2003-07-02 Axis Shield Asa Assay

Also Published As

Publication number Publication date
EP1844332A1 (en) 2007-10-17
WO2006082318A1 (en) 2006-08-10

Similar Documents

Publication Publication Date Title
TW200716981A (en) Method for the quantitative measurement of analytes in a liquid sample by immunochromatography
BR112013031284A2 (en) compositions, methods, and kits for quantifying target analytes in a sample
WO2011142827A3 (en) Diagnostic markers for neuropsychiatric disease
WO2009112594A3 (en) Assays
AR053948A1 (en) DETECTION OF AN ANCIENT DIANA INDEPENDENTLY FROM THE PRESENCE OR ABSENCE OF A CORRESPONDING THERAPEUTIC ANTIBODY
BR112014031958A2 (en) bag3 as tissue marker and biochemical serum
BRPI0916624A2 (en) selective hepcidin-25 monoclonal antibodies, their uses, as well as method and kit for quantifying the amount of hepcidin-25 protein in a tissue or biological fluid sample
BR112013025024A2 (en) system for quantitative chemical analysis of samples, particularly in the medical field, with instrumentation response calibration of the instrumentation used to detect quantitative data of the analytes present in the analyzed samples and the corresponding method
EP2821497A3 (en) Reagent composition for biosensor and biosensor having the same
WO2014074835A8 (en) Antibody compositions and immunoassay methods to detect isoforms of anti-mullerian hormone
ES2674177T3 (en) Serum preparation
EP4234710A3 (en) Method for accurate diagnosis of a disease targeting biomarkers in liquid biopsy
BR112016024730A2 (en) immunochromatographic analysis device, method and kit
BR112012033591A2 (en) process of detection of molecular interactions.
PE20160657A1 (en) COMPOSITIONS AND METHODS TO IDENTIFY A RISK OF CANCER IN A SUBJECT
DK2118666T3 (en) Method of normalizing the concentration of analytes in a urine sample
BR112014009223A8 (en) method for the diagnosis of niemann-pick disease
AR052474A1 (en) METHOD OF QUANTITATIVE MEASUREMENT BY IMMUNOCROMATOGRAPHY OF ANALYTS IN A LIQUID SAMPLE
EA201400113A1 (en) BIOLOGICAL MICROCHIP FOR QUANTITATIVE DETERMINATION OF IMMUNOGLOBULINS OF CLASSES E AND G IN BIOLOGICAL LIQUIDS, METHOD OF ANALYSIS WITH ITS USE AND SET OF REAGENTS, IT'S CHAPTER
WO2013167727A3 (en) Method for determining arthritis relapse risk
JP2009204612A5 (en)
AR091836A1 (en) METHOD FOR PURIFYING THE TRANSGENIC FACTOR VII
WO2011113813A3 (en) Assay for analytes based on aggregation
AR058510A1 (en) PROCEDURE FOR DIAGNOSIS OF HEPATIC DISEASES AND SAMPLING OF MOLECULES FOR THE TREATMENT OF THESE DISEASES
BRPI0812348B8 (en) method for down-regulating or down-regulating the biological function of a protein, chimeric molecule, recombinant vector and method for isolating a protein from a sample

Legal Events

Date Code Title Description
FA Abandonment or withdrawal